- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 9/90 - Isomerases (5.)
Patent holdings for IPC class C12N 9/90
Total number of patents in this class: 1490
10-year publication summary
98
|
142
|
122
|
140
|
157
|
137
|
132
|
126
|
131
|
42
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
CJ Cheiljedang Corporation | 2964 |
79 |
Evolva SA | 181 |
32 |
The Regents of the University of California | 18943 |
26 |
DSM IP Assets B.V. | 5856 |
23 |
Samyang Corporation | 368 |
22 |
Genomatica, Inc. | 514 |
19 |
Jiangnan University | 1410 |
18 |
Bonumose, Inc. | 28 |
18 |
BASF SE | 19740 |
15 |
National University Corporation Kagawa University | 213 |
15 |
Novozymes A/S | 3314 |
14 |
Givaudan SA | 1760 |
14 |
Ginkgo BioWorks, Inc. | 228 |
12 |
Korea University Research and Business Foundation | 2561 |
12 |
Matsutani Chemical Industry Co., Ltd. | 88 |
12 |
Massachusetts Institute of Technology | 9795 |
11 |
Daesang Corporation | 261 |
11 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
11 |
Centre National de La Recherche Scientifique | 9632 |
10 |
Codexis, Inc. | 776 |
10 |
Other owners | 1106 |